Literature DB >> 12527706

Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data.

Antoine A Robbesom1, Elly M M Versteeg, Jacques H Veerkamp, J Han J M van Krieken, Hans J Bulten, Hans T J Smits, Luuk N A Willems, Cees L A van Herwaarden, P N Richard Dekhuijzen, Toin H van Kuppevelt.   

Abstract

Small human lung specimens are frequently used for cell biological studies of the pathogenesis of emphysema. In general, lung function and other clinical parameters are used to establish the presence and severity of emphysema/chronic obstructive pulmonary disease without morphological analysis of the specimens under investigation. In this study we compared three morphological methods to analyze emphysema, and evaluated whether clinical data correlate with the morphological data of individual lung samples. A total of 306 lung specimens from resected lung(lobes) from 221 patients were inflated and characterized using three morphological parameters: the Destructive Index, the Mean Linear Intercept, and Section Assessment. Morphological data were related to each other, to lung function data, and to smoking behavior. Significant correlations (P < .001) were observed between Section Assessment and Destructive Index (r = 0.92), Mean Linear Intercept with Destructive Index (r = 0.69) and Mean Linear Intercept with Section Assessment (r = 0.65). Section Assessment, being much less time consuming than Mean Linear Intercept and Destructive Index, is the parameter of choice for initial analysis. Destructive Index is the most sensitive parameter. There was a significant (P < .001), but weak correlation for all three parameters with the diffusion capacity for CO (K(CO)) (Destructive Index: r = -0.28; Mean Linear Intercept: r = -0.34; Section Assessment: r = -0.32), and with FEV(1)/IVC (Destructive Index: r = -0.29; Mean Linear Intercept: r = -0.33; Section Assessment: r = -0.28), but not with other lung function parameters. A significant difference (P < .05) between (ex-) smokers and never-smokers was observed for Destructive Index and Section Assessment. It is concluded that the application of the three morphological parameters represents a useful method to characterize emphysematous lesions in a (semi-)quantitative manner in small human lung specimens, and that Section Assessment is a suitable and fast method for initial screening. The extent of emphysema of individual lung specimens should be established by means of morphometry, rather than lung function data.

Entities:  

Mesh:

Year:  2003        PMID: 12527706     DOI: 10.1097/01.MP.0000043519.29370.C2

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  29 in total

1.  Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.

Authors:  Ming Zhu; Christopher Hug; David I Kasahara; Richard A Johnston; Alison S Williams; Norah G Verbout; Huiqing Si; Jordan Jastrab; Amit Srivastava; Erin S Williams; Barbara Ranscht; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-13       Impact factor: 6.914

2.  Transcriptomic modifications in developmental cardiopulmonary adaptations to chronic hypoxia using a murine model of simulated high-altitude exposure.

Authors:  Sheila Krishnan; Robert S Stearman; Lily Zeng; Amanda Fisher; Elizabeth A Mickler; Brooke H Rodriguez; Edward R Simpson; Todd Cook; James E Slaven; Mircea Ivan; Mark W Geraci; Tim Lahm; Robert S Tepper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-08       Impact factor: 5.464

3.  Activated charcoal filter effectively reduces p-benzosemiquinone from the mainstream cigarette smoke and prevents emphysema.

Authors:  Neekkan Dey; Archita Das; Arunava Ghosh; Indu B Chatterjee
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

4.  β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice.

Authors:  Anita R Iskandar; Chun Liu; Donald E Smith; Kang-Quan Hu; Sang-Woon Choi; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-28

5.  Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

Authors:  M R Starkey; D H Nguyen; A T Essilfie; R Y Kim; L M Hatchwell; A M Collison; H Yagita; P S Foster; J C Horvat; J Mattes; P M Hansbro
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

6.  Morphological mechanism of the development of pulmonary emphysema in klotho mice.

Authors:  Atsuyasu Sato; Toyohiro Hirai; Akihiro Imura; Naoko Kita; Akiko Iwano; Shigeo Muro; Yo-ichi Nabeshima; Bela Suki; Michiaki Mishima
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

7.  PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3- and SP-C-associated cell death/injury activity.

Authors:  Yih-Sheng Yang; Meng-Chun W Yang; Yuhong Guo; Olatunji W Williams; Jonathan C Weissler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-02       Impact factor: 5.464

8.  Cellular and molecular mechanisms of cigarette smoke-induced lung damage and prevention by vitamin C.

Authors:  Shuvojit Banerjee; Ranajoy Chattopadhyay; Arunava Ghosh; Hemanta Koley; Koustubh Panda; Siddhartha Roy; Dhrubajyoti Chattopadhyay; Indu B Chatterjee
Journal:  J Inflamm (Lond)       Date:  2008-11-11       Impact factor: 4.981

9.  Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.

Authors:  Yu-Tao Li; Bei He; Yu-Zhu Wang; Jing Wang
Journal:  Respir Res       Date:  2009-08-25

10.  Comparison of two quantitative methods of discerning airspace enlargement in smoke-exposed mice.

Authors:  Richard E Jacob; James P Carson; Kathy M Gideon; Brett G Amidan; Cathie L Smith; K Monica Lee
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.